These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1244 related items for PubMed ID: 26686287

  • 1. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
    Rai SN, Yadav SK, Singh D, Singh SP.
    J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX, Chen WF, Xie JX, Wong MS.
    Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
    [Abstract] [Full Text] [Related]

  • 3. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK.
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R, Bastola T, Lee DH, Seo J.
    Int J Mol Sci; 2022 Feb 21; 23(4):. PubMed ID: 35216503
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB, Sturgess NC, Butt M, Wolf JC, Zadory D, Beck M, Mathews JM, Tisdel MO, Minnema D, Travis KZ, Cook AR, Botham PA, Smith LL.
    Neurotoxicology; 2013 Jul 21; 37():1-14. PubMed ID: 23523781
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats.
    Xu CL, Qu R, Zhang J, Li LF, Ma SP.
    Fitoterapia; 2013 Oct 21; 90():112-8. PubMed ID: 23876367
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J, Carrillo-S C, García E, Ruiz-Mar G, Pérez-Tamayo R, Chavarría A.
    Toxicology; 2014 May 07; 319():38-43. PubMed ID: 24607817
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
    Guo Z, Xu S, Du N, Liu J, Huang Y, Han M.
    Neurosci Lett; 2016 Mar 11; 616():152-9. PubMed ID: 26827716
    [Abstract] [Full Text] [Related]

  • 12. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S, Ranju V, Kalaivani P, Priya RJ, Sumathy H, Sunil AG, Babu CS.
    Neuropharmacology; 2013 Oct 11; 73():98-110. PubMed ID: 23747572
    [Abstract] [Full Text] [Related]

  • 13. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
    Araki T, Muramatsu Y, Tanaka K, Matsubara M, Imai Y.
    Neurosci Lett; 2001 Oct 12; 312(1):50-4. PubMed ID: 11578843
    [Abstract] [Full Text] [Related]

  • 14. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan 12; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 15. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity.
    Oeckl P, Ferger B.
    Neuroscience; 2016 Nov 19; 337():218-223. PubMed ID: 27651149
    [Abstract] [Full Text] [Related]

  • 16. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.
    Synapse; 2003 Jan 19; 47(1):10-4. PubMed ID: 12422368
    [Abstract] [Full Text] [Related]

  • 17. Preventive role of PD-1 on MPTP-induced dopamine depletion in mice.
    Jung HW, Son HY, Jin GZ, Park YK.
    Cell Biochem Funct; 2010 Apr 19; 28(3):217-23. PubMed ID: 20186864
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model.
    Yadav SK, Prakash J, Chouhan S, Westfall S, Verma M, Singh TD, Singh SP.
    Neurochem Int; 2014 Jan 19; 65():1-13. PubMed ID: 24333323
    [Abstract] [Full Text] [Related]

  • 19. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease.
    Haque ME, Azam S, Akther M, Cho DY, Kim IS, Choi DK.
    Int J Mol Sci; 2021 Apr 28; 22(9):. PubMed ID: 33925146
    [Abstract] [Full Text] [Related]

  • 20. A novel anti-Parkinsonian agent, zonisamide, attenuates MPTP-induced neurotoxicity in mice.
    Yano R, Yokoyama H, Kuroiwa H, Kato H, Araki T.
    J Mol Neurosci; 2009 Sep 28; 39(1-2):211-9. PubMed ID: 19199078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.